Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel FeX3 catalyzed method for pyrroles replaces noble metals. High purity, green chemistry, and cost-effective solutions for API manufacturing.
Novel synthesis of axial chiral cyclopentenyl indole-naphthyl compounds via chiral phosphoric acid catalysis. Offers high ee, mild conditions, and scalable production for pharmaceutical applications.
Novel chiral phosphoric acid catalysis for high-purity anticancer intermediates. Cost-effective scale-up and reliable supply chain solutions for global pharmaceutical manufacturing partners.
Patent CN111777637B discloses a novel oxindole-derived phosphine catalyst enabling mild asymmetric cyclizations with excellent yields and supply chain stability.
Novel Pd-catalyzed synthesis offers high enantioselectivity. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN117304094A reveals visible-light method for high-purity 3-trifluoromethylpyridine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Rh-catalyzed method for trifluoromethyl enaminones. Reduces cost and improves scalability for pharmaceutical manufacturing.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 1,2,4-triazoles. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity intermediates.
Novel bismuth-catalyzed route offers high yields and recyclability for asymmetric triarylmethane derivatives, reducing costs in pharmaceutical intermediate manufacturing.
Novel patent CN114573512B enables mild visible light synthesis. Reduces toxicity and cost for pharmaceutical intermediates manufacturing supply chain.
Patent CN107602577A details a novel organocatalytic route for chiral oxindole spiropiperidines. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel synthesis of axial chiral isopyrone-indole derivatives via phase transfer catalysis. High enantioselectivity and cytotoxic activity for pharmaceutical applications.
Advanced synthesis of spiro quaternary ammonium salts via kinetic resolution. Offers superior enantioselectivity for amino acid synthesis with scalable industrial processes.
Patent CN105622537A details a Lewis base-catalyzed route for isoxazoles, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN107936025B reveals a metal-free NHC catalytic route for high-purity chiral pyrazolidinones, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN114057717B reveals novel ligand synthesis enhancing enantioselectivity. Delivers substantial cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel synthesis method patent CN116199614B offers high enantioselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel iridium-catalyzed hydrogen transfer cyclization for tetrahydroquinoline pyrans. High atom economy, one-pot synthesis, ideal for reliable pharmaceutical intermediate supply chains.
Novel chiral phase transfer catalysis synthesis for anticancer intermediates. Offers mild conditions, high ee, and scalable production for pharmaceutical supply chains.